Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Thyroid : Official Journal of the American Thyroid Association|December 1, 2020
Growth Differentiation Factor 15 is a Cancer Cell-Induced Mitokine That Primes Thyroid Cancer Cells for InvasivenessYea Eun Kang, Jin Man Kim, Mi Ae Lim, et al.Annals of Surgery|March 13, 2023
Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort StudyHyeonuk Hwang, June Young Choi, Hyeong Won Yu, et al.Surgery|May 22, 2018
Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in KoreaKyong Yeun Jung, Seok-Mo Kim, Min Joo Kim, et al.Thyroid : Official Journal of the American Thyroid Association|June 5, 2019
Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro)Sung Hye Kong, Junsun Ryu, Min Joo Kim, et al.Nature Communications|July 14, 2017
Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancerHo-Young Son, Yul Hwangbo, Seong-Keun Yoo, et al.Thyroid : Official Journal of the American Thyroid Association|June 14, 2022
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro)Yul Hwangbo, June Young Choi, Eun Kyung Lee, et al.Thyroid : Official Journal of the American Thyroid Association|October 7, 2022
Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in KoreaEun Kyung Lee, Jae Hoon Moon, Yul Hwangbo, et al.The Journal of Clinical Endocrinology and Metabolism|November 28, 2020
Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid MicrocarcinomaJae Hoon Moon, Chang Hwan Ryu, Sun Wook Cho, et al.Elife|April 10, 2020
High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone lossOk-Hee Kim, Carmen J Booth, Han Seok Choi, et al.Endocrinology and Metabolism (Seoul, Korea)|August 17, 2018
Corrigendum: Author's Name Correction. Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro)Jae Hoon Moon, Ji Hoon Kim, Eun Kyung Lee, et al.Pageof 15